Specialty	Neurology
Clinical Interests	AIDS/HIV
	Electrodiagnostic Testing
	Electromyography / EMG
	Neurology
	Neuromuscular Disease
	Neuropathy
Languages	English
	Spanish
Gender	Female
E-mail	jessica.robinson@mssm.edu
Education and Training	MD, Mount Sinai School of Medicine
	Internship, Internal Medicine, St. Vincent's Hospital
	Residency, Neurology, Mount Sinai Hospital
	Fellowship, Neurophysiology, Mount Sinai Hospital

Dr. Robinson-Papp sees patients with a wide variety of neurologic disorders.  Her special interests include neuropathy and the neurologic complications of HIV/AIDS.  In addition to neurologic consults, Dr. Robinson-Papp performs electromyography (EMG) and autonomic testing to aid in the diagnosis of disorders of the peripheral nervous system, as well as electrodiagnosis for disorders of the pelvic floor.  She is board certified in neurology by the American Board of Psychiatry and Neurology and in EMG by the American Board of Electrodiagnostic Medicine.

Dr. Robinson-Papp is also involved in medical education, and oversees the evaluation of inpatients by the NeuroAIDS consult service, and outpatients in the neurology division of the Jack Martin Fund Clinic.

Dr. Robinson-Papp plays a key role in the neurophysiology and NeuroAIDS fellowship training programs, and provides training to healthcare providers visiting Mount Sinai through the AIDS Institute and Arthur Ashe scholarship programs.  She is a lecturer for the Mount Sinai Institute for NeuroAIDS disparities and the AIDS Education and Training Center (AETC).

Education and Training	MD, Mount Sinai School of Medicine
	Internship, Internal Medicine, St. Vincent's Hospital
	Residency, Neurology, Mount Sinai Hospital
	Fellowship, Neurophysiology, Mount Sinai Hospital
Board Certification	Neurology

Specialty	Neurology
Clinical Interests	AIDS/HIV
	Electrodiagnostic Testing
	Electromyography / EMG
	Neurology
	Neuromuscular Disease
	Neuropathy
Languages	English
	Spanish
Board Certification	Neurology

The neurologic complications of HIV/AIDS
Observational studies:  

• Manhattan HIV Brain Bank (www.mhbb.org) is a longitudinal organ donation study examining the neurologic, neuropsychological, psychiatric, and pathological effects of HIV.
• CNS HIV Antiretroviral Therapy Effects Research (CHARTER) https://www.charterresource.ucsd.edu/ is a longitudinal study of the neurologic effects of HIV.
• Clinical trials:
• A randomized, rater-blinded study to explore the effect of mefloquine in subjects with progressive multifocal leukoencephalopahty (PML).
• A phase II, randomized, placebo-controlled, double-blind study of minocycline in the treatment of HIV-associated cognitive impairment  
• A phase II, randomized, double-blind, placebo-controlled study of methadone and combination of methadone and SAB378 in HIV-associated painful peripheral neuropathy: a multicenter trial of the Neurologic AIDS Research Consortium (NARC)

Peripheral neuropathy and neuromuscular disease:

• The effect of diflunisal (IND 68092) on familial amyloidosis: A randomized, double-blind, placebo-controlled, international multi-center trial of diflunisal on neurologic disease progression in 200 familial amyloid subjects.
• A phase 1 dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of XL019 administered to subjects with myelofibrosis.
• A randomized double-blind, placebo-controlled, cross-over, multi-center study of eculizumab in patients with generalized myasthenia gravis who have moderate to severe muscle weakness despite treatment with immunosuppressants.

Peripheral neuropathy and neuromuscular disease

• The effect of diflunisal (IND 68092) on familial amyloidosis: A randomized, double-blind, placebo-controlled, international multi-center trial of diflunisal on neurologic disease progression in 200 familial amyloid subjects.
• A phase 1 dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of XL019 administered to subjects with myelofibrosis.
• A randomized double-blind, placebo-controlled, cross-over, multi-center study of eculizumab in patients with generalized myasthenia gravis who have moderate to severe muscle weakness despite treatment with immunosuppressants.

Robinson-Papp J, Byrd D, Rivera Mindt M. Motor function and HIV-associated cognitive impairment in a HAART era cohor. Arch Neurol 2008; 65(8): 1096-1101.

Robinson-Papp J, Simpson DM. Neuromuscular complications of human immunodeficiency virus infection. Phys Med Rehabil Clin N Am 2008; 19(1): 81-96.

Robinson Papp J, Simpson DM. Neurological Complications of HIV in the Spinal Cord and Peripheral Nervous System. In: Cohen MA, Gorman J, editors. Comprehensive Textbook of AIDS Psychiatry. New York, Oxford University Press;.

Gonzalez-Duarte A, Robinson-Papp J, Simpson DS. Diagnosis and management of HIV-associated neuropathy. Neurologic Clinics 2008; 26(3): 821-832.

Robinson Papp J, Simpson DM. Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Medicine 2007; 8(S2): S43-S49.

Carver AC, Robinson Papp J, Ufford LJ. Quintessentials: palliative care in neurology, pointers for practice. Continuum 2005; 11(6): 155-171.

Carver AC, Ufford LJ, Robinson Papp J. Patient management problem. Continuum 2005; 11(6): 228-237.

Roane DM, Rogers JD, Robinson JH, Feinberg TE. Delusional misidentification in association with parkinsonism. J Neuropsychiatry Clin Neurosci 1998; 10(2): 194-198.